Movers & Shakers

Premium

Vermillion has appointed Donald Munroe as chief scientific officer and vice president of research and development. Eric Fung, the company's former chief scientific officer, will now serve as chief medical officer.

Munroe was previously vice president of immunoassay research and development at Beckman Coulter. Before that he held several management roles at Invitrogen and worked in pharmaceutical discovery research experience at the R.W. Johnson Pharmaceutical Research Institute.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.